Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry

Molecular Genetics and Metabolism

Volumn 79, Issue 3, 2003, Pages 189-196

  Valianpour, Fredoen ^a   Selhorst, Jacqueline J M ^a   Van Lint, Lia E M ^a   Van Gennip, Albert H ^a   Wanders, Ronald J A ^a   Kemp, Stephan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Diagnosis; ESI MS; Peroxisome; Very long chain fatty acids; VLCFA; X linked adrenoleukodystrophy

Indexed keywords

LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EXTRACTION; FATTY ACID ANALYSIS; FEMALE; FIBROBLAST; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID HYDROLYSIS; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; VALIDATION PROCESS; X CHROMOSOME LINKED DISORDER; ZELLWEGER SYNDROME;

EID: 0037677622     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00098-2     Document Type: Article

References (12)

1. Moser H.W., Smith K.D., Watkins P.A., Powers J., Moser A.B. X-linked adrenoleukodystrophy. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 2002;3257-3301 McGraw-Hill, New York.
2. Bezman L., Moser A.B., Raymond G.V., Rinaldo P., Watkins P.A., Smith K.D., Kass N.E., Moser H.W. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann. Neurol. 49:2001;512-517.
3. Moser A.B., Kreiter N., Bezman L., Lu S., Raymond G.V., Naidu S., Moser H.W. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45:1999;100-110.
4. Moser H.W., Moser A.B., Trojak J.E., Supplee S.W. Identification of female carriers of adrenoleukodystrophy. J. Pediatr. 103:1983;54-59.
5. Moser H.W., Moser A.B., Frayer K.K., Chen W., Schulman J.D., O'Neill B.P., Kishimoto Y. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology. 31:1981;1241-1249.
6. Moser H.W., Moser A.B. Measurement of saturated very long chain fatty acids in plasma. Hommes F.A. Techniques in Diagnostic Human Biochemical Genetics. 1991;177-191 Wiley-Liss, New Yok.
7. Stellaard F., ten Brink H.J., Kok R.M., van den Heuvel L., Jakobs C. Stable isotope dilution analysis of very long chain fatty acids in plasma, urine and amniotic fluid by electron capture negative ion mass fragmentography. Clin. Chim. Acta. 192:1990;133-144.
8. Vallance H., Applegarth D. An improved method for quantification of very long chain fatty acids in plasma. Clin. Biochem. 27:1994;183-186.
9. Vreken P., van Lint A.E., Bootsma A.H., Overmars H., Wanders R.J., van Gennip A.H. Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 713:1998;281-287.
10. Johnson D.W. A rapid screening procedure for the diagnosis of peroxisomal disorders: quantification of very long-chain fatty acids, as dimethylaminoethyl esters, in plasma and blood spots, by electrospray tandem mass spectrometry. J. Inherit. Metab. Dis. 23:2000;475-486.
11. ten Brink H.J., Jacobs C., Bickelhaupt F. Synthesis and applications of isotopically labeled compounds. Baillie T.J., Jones J.R. Synthesis and Applications of Isotopically Labelled Compounds. 1989;723-726 Elsevier, Amsterdam.
12. Kemp S., Wei H.W., Lu J.F., Braiterman L.T., McGuinness M.C., Moser A.B., Watkins P.A., Smith K.D. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat. Med. 4:1998;1261-1268.